Tannin Phytocomplex Improves IBS‐D Symptoms and Gut‐Brain Markers: Prospective Pilot Study
Molecular Nutrition & Food Research · 2026
DOI: 10.1002/mnfr.70451 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Molecular Nutrition & Food Research, 2026. Verfasst von Silvia Molino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Silvateam Spa, R&D Unit, San Michele Mondovì, Italy. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Tannins. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital de Clínicas José de San Martín.
Abstract (Originalsprache)
Diarrhea‐predominant irritable bowel syndrome (IBS‐D) is a multifactorial disorder involving gut‐brain axis dysregulation, altered barrier integrity, microbial imbalance, and stress‐related mechanisms, with limited nutritional strategies targeting these pathways. Tannin‐rich extracts may exert barrier‐protective, microbiota‐modulating, and stress‐related effects. In a prospective before‐after pilot study (NCT05207618), 28 adults with IBS‑D completed a 60‑day tannin‐based supplementation (480 mg/day). Outcomes included IBS Severity Scoring System (IBS‐SSS), bowel habits, somatization, perceived stress, serum zonulin, faecal short‐chain fatty acids, and hydrogen breath test. Linear mixed models assessed changes over time. IBS‐SSS decreased by an estimated mean of 70 points (95% CI: 34–107; p < 0.0001); stool consistency improved by 1.38 (95% CI: 0.72 to 2.05; p < 0.0001), and bowel movements/day decreased by 0.84 (95% CI: 0.08 to 1.71; P = 0.028). Somatization and stress scores declined significantly (both P ≤ 0.003). Zonulin dropped ( P < 0.0001), butyrate increased ( p = 0.001), and propionate decreased ( p = 0.017). Hydrogen‐positive subjects at baseline (3/28) were all negative at 60 days. No adverse events occurred. This pilot suggests a tannin‐based phytocomplex may improve gastrointestinal and psychological symptoms in IBS‐D, with biomarker changes indicating enhanced barrier function and microbial metabolism. Larger trials are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Silvateam Spa, R&D Unit, San Michele Mondovì, Italy.
- Universidad de Buenos Aires, Hospital de Clínicas José de San Martin, Sector Neurogastroenterología del Servicio de Gastroenterología, Buenos Aires, Argentina.
- University of Lund, Neuroinflammation, Lund, Sweden.
- Universidad de Buenos aires/ IBIMOL, Hospital de Clínicas José de San Martin, Programa de Estudios Pancreáticos, Buenos Aires, Argentina.
- Universidad de Buenos Aires, Hospital de Clínicas José de San Martin, Servicio de Gastroenterología, Buenos Aires, Argentina.
Förderung
- Hospital de Clínicas José de San Martín
Zitieren
APA
Molino, S., Piskorz, M. M., Lerma-Aguilera, A., Mingorance, F. L., Gutierrez, C., Montero, J. M., Uehara, T., Hashimoto, H., Ballerga, E. G., & Olmos, J. A. (2026). Tannin Phytocomplex Improves IBS‐D Symptoms and Gut‐Brain Markers: Prospective Pilot Study. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70451
Vancouver
Molino S, Piskorz MM, Lerma-Aguilera A, Mingorance FL, Gutierrez C, Montero JM, et al. Tannin Phytocomplex Improves IBS‐D Symptoms and Gut‐Brain Markers: Prospective Pilot Study. Molecular Nutrition & Food Research. 2026. doi:10.1002/mnfr.70451
BibTeX
@article{Molino2026,
author = {Molino, Silvia and Piskorz, María M and Lerma-Aguilera, Alberto and Mingorance, Fabiana López and Gutierrez, Cielo and Montero, Juan M and Uehara, Tatiana and Hashimoto, Harumi and Ballerga, Esteban González and Olmos, Jorge A},
title = {Tannin Phytocomplex Improves IBS‐D Symptoms and Gut‐Brain Markers: Prospective Pilot Study},
journal = {Molecular Nutrition & Food Research},
year = {2026},
doi = {10.1002/mnfr.70451}
}
EUVIMED